Central Hospital of Nanyang

Nanyang, China

Central Hospital of Nanyang

Nanyang, China

Time filter

Source Type

Wang A.,Central Hospital of Nanyang | Zhang B.,Central Hospital of Nanyang | Zhang J.,Central Hospital of Nanyang | Wu W.,Jilin University | Wu W.,Wenzhou Medical College
Oncology Reports | Year: 2013

Brain glioma is the most common malignant intracranial tumor and has become the focus of research on diseases of the central nervous system due to its high incidence and poor prognosis. As a small-molecule inhibitor of X-linked inhibitor of apoptosis protein (XIAP), embelin has the ability to specifically inhibit XIAP to control and regulate the apoptosis of various types of tumor cells. However, to date, the mechanism of action for this effect is not well understood. The aim of this study was to investigate the role that the mitochondrial pathway plays in embelin-induced brain glioma cell apoptosis and the effect of embelin on the cell cycle. Brain glioma cells were treated with different doses of embelin. The MTT method was used to determine cell proliferation, and flow cytometry was used to determine apoptosis, as well as changes in the cell cycle and cell mitochondrial membrane potential. Western blot analysis was performed to determine the expression levels of apoptosis-associated proteins, Bcl-2, Bcl-xL, Bax and Bak as well as cytochrome c. We found that embelin induced a time- and dose-dependent apoptosis of brain glioma cells, and that it could arrest the cell cycle in the G0/G1 phase. Embelin also caused changes in brain glioma cell mitochondrial membrane potential. Additionally, embelin regulated the shifting of Bax and Bcl-2 to promote the mitochondrial release of cytochrome c, thus activating the caspase proteins to cause apoptosis. Thus, embelin induces apoptosis in brain glioma cells which is closely associated with the mitochondrial pathway.


Liu L.,Fudan University | Liu L.,Central Hospital of Nanyang | Wu H.,Xian XD Group Hospital | Wang Q.,Fudan University | And 4 more authors.
Endocrine Journal | Year: 2012

Autoimmune thyroid disease (AITD) is a multifactorial disease with a genetic susceptibility and environmental factors. The thyroid stimulating hormone receptor gene (TSHR) which is expressed on the surface of the thyroid epithelial cell is thought to be the main auto-antigen and a significant candidate for genetic susceptibility to AITD. This case-control study aimed at evaluating the association between single nucleotide polymorphisms (SNP) of TSHR and AITD in a Chinese Han population. We recruited 404 patients with Graves' disease (GD), 230 patients with Hashimoto's thyroiditis (HT) and 242 healthy controls. The Matrix Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometer (MALDI-TOFMS) Platform was used to detect five SNPs (rs179247, rs12101255, rs2268475, rs1990595, and rs3783938) in TSHR gene. The frequencies of allele T and TT genotype of rs12101255 in GD patients were significantly increased compared with those of the controls (P=0.004/0.015, OR=1.408/1.446). The allele A frequency of rs3783938 was greater in HT patients than in the controls (P=0.025, OR=1.427). The AT haplotype (rs179247-rs12101255) was associated with an increased risk of GD (P=0.010, OR=1.368). The allele A of rs179247 was associated with ophthalmopathy in GD patients. These data suggest that the polymorphisms of rs12101255 and rs3783938 are associated with GD and HT, respectively. © The Japan Endocrine Society.


PubMed | PLA 81 Hospital, Central Hospital of Nanyang and China Pharmaceutical University
Type: Journal Article | Journal: Molecular medicine reports | Year: 2016

Xanthine oxidase (XOD) and paraoxonase1 (PON1) are important enzymes in redox reactions invivo, and are predominantly synthesized by the liver. The aim of the present study was to investigate the redox state in nonalcoholic fatty liver disease, and determine the association between the activities of XOD and PON1 and the severity of NAFLD. SpragueDawley rats were randomly divided into control, model and lipoic acid (high and low dose) groups. The rats in the NAFLD model were induced by feeding a high fat diet for 12weeks and the invitro cell model of hepatocyte steatosis was induced by treating L02 cells with oleic acid for 24h. The body weight, liver function, lipid and oxidative stress indices, and histological features of the liver were examined in the rats. Compared with the control group, the rats in the NAFLD model group showed impaired liver function, lipid disorders and damage from oxidative stress. The serum activity of XOD increased significantly from the 4th week and was markedly higher, compared with that in the control group, reaching a peak in the 12th week. The activity of PON1 was negatively correlated with that of XOD. Compared with the control cells, the activity of XOD and levels of freefatty acids were significantly higher, and the activity of PON1 was significantly lower in the NAFLD L02 cell model. All the above indicators were significantly improved by treatment with the antioxidant, lipoic acid. The activities of XOD and PON1 may be promising as markers in a noninvasive approach for detecting the severity of NAFLD clinically. lipoic acid had protective effects on the NAFLD rats, and the potential mechanism may be associated with the inhibition of oxidative stress and lipid peroxidation.


Zhou J.,Central Hospital of Nanyang | Zhang B.-C.,Central Hospital of Nanyang
Chinese Journal of Tissue Engineering Research | Year: 2015

BACKGROUND: Previous studies have found that the expression level of miR-486 in glioma stem cells CD133+) is significantly down-regulated compared with that in glioma non-stem cells CD133), but the effect of down-regulation of miR-486 on CD133+ cells remains unclear. OBJECTIVE: To explore the effect of miR-486 on CD133+ cells. METHODS: CD133+ glioma stem cells and CD133 glioma cells were separated from U87 cells by flow cytometer. miR-486 overexpression glioma stem cells were constructed by lipofection transfection. RESULTS AND CONCLUSION: After sorting and purification, the content of the CD133+ fraction was enriched up to 83. 5%. The expression level of miR-468 in CD133+ glioma stem cells was obviously down-regulated compared with that in CD133 glioma cells. CD133+ glioma stem cells overexpressing miR-486 were fabricated successfully. Results from in vitro experiments showed that miR-486 overexpression could dramatically decrease the proliferation of glioma stem cells, induce a cell cycle arrest in G1/S phase for CD133+ glioma stem cells and promote cell apoptosis. These findings suggest that miR-486 can be a suppressor of glioma stem cells, which offers a novel potential therapeutic target for glioma stem cells and human glioma. © 2015, Journal of Clinical Rehabilitative Tissue Engineering Research. All rights reserved.


Xu N.,Central Hospital of Nanyang | Yang Y.-R.,Central Hospital of Nanyang | Jin W.-B.,Central Hospital of Nanyang
World Chinese Journal of Digestology | Year: 2014

Aim: To observe the effects of sitagliptin and repaglinide in glycemic control and gastrointestinal hormone regulation in patients with diabetic enteropathy.Methods: Thirty diabetic enteropathy outpatients were randomly divided into either a repaglinide group or a sitagliptin group, with 15 cases in each group. The sitagliptin group was given sitagliptin phosphate orally 100 mg per day, and the repaglinide group was given repaglinide 0.5 mg, three times a day. Glycemic control effects and gastrointestinal hormone levels were determined before and after drug administration.Results: In both the sitagliptin group and repaglinide group, HbA1c, fasting plasma glucose, 2 h postprandial glucose (2 h PBG) were significantly lower after treatment than before treatment (P<0.05). Serum levels of motilin (MTL), gastrin (GAS), and somatostatin (SS) were also significantly lower after treatment than before treatment in both groups, while glucagon-like peptide-1 (GLP-1) was significantly higher after treatment than before treatment (P<0.05). After treatment, serum levels of MTL and GAS were significantly lower, and GLP-1 was significantly higher in the sitagliptin group than in the repaglinide group (P<0.05).Conclusion: Sitagliptin and repaglinide have good effects in glycemic control and modulating gastrointestinal function. Ruigelieting has a better effect in regulating gastrointestinal hormones. © 2014 Baishideng Publishing Group Inc. All rights reserved.


Zhang Z.,Central Hospital of Nanyang | Yan Z.,Central Hospital of Nanyang | Yuan Z.,Central Hospital of Nanyang | Sun Y.,Central Hospital of Nanyang | And 2 more authors.
Tumor Biology | Year: 2015

Sphingosine kinase 1 (SphK1) is an oncogenic enzyme promoting transformation, proliferation, and angiogenesis of a number of human tumors. However, its effect on hepatocellular carcinoma (HCC) behavior has not been fully clarified. The purpose of this study was to determine the correlation between HCC and SphK1, and to evaluate the effect of SphK1 inhibitor N,N-dimethylsphingosine (DMS) in HCC. The expression of SphK1 was measured in tissue samples from 76 HCC and paired adjacent noncancerous liver tissues (NT) by immunohistochemistry, quantitative real-time PCR, and Western blotting analysis. The effect of DMS was tested on HCC cells by evaluating cell viability in vitro. Transwell cell migration and invasion assay were carried out for functional analysis. Furthermore, Western blotting analysis was performed to examine the impact of DMS on the PI3K/Akt/NF-kB signaling. High expression of Sphk1 was observed in 84.21 % (64/76) of the HCC versus 15.79 % (12/76) of the adjacent non-tumorous liver tissues; the difference of Sphk1 expression between HCC and the adjacent non-tumorous liver tissues was statistically significant (P < 0.001). The results were confirmed by Western blot analyses and quantitative real-time PCR. DMS inhibited the proliferation of SK-Hep1 and MHCCLM3 cells which have a relatively high level of SphK1 in a time- and concentration-dependent manner, and the invasion and migration of SK-Hep1 cells were distinctly suppressed after undergoing treatment with DMS. Furthermore, DMS markedly suppressed the expression of phosphorylations of Akt and NF-κB in HCC cells. Our data suggest that the pathogenesis of human HCC maybe mediated by Sphk1, and the specific Sphk1 inhibitor DMS can play a therapeutic role in the treatment of HCC and thus, Sphk1 could represent selective targets for the molecularly targeted treatments of HCC. © 2014, International Society of Oncology and BioMarkers (ISOBM).


Zhang S.-J.,Central Hospital of Nanyang | Wang G.-Z.,Central Hospital of Nanyang
World Chinese Journal of Digestology | Year: 2015

AIM: To compare the clinical effects of laparoscopic vs open surgery for repair of gastroduodenal ulcer perforation. METHODS: Nine ty- two pa t i ent s wi t h gastroduodenal ulcer perforation were divided into a study group (45 cases) and a control group (47 cases). The study group received laparoscopic surgery, and the control group received open surgery. The operation situation, pos toperat ive recovery, pos toperat ive hospitalization duration, total treatment cost, the rate of complications, and ulcer healing were compared for the two groups. RESULTS: The operation time for the study group was significantly longer than that for the control group (118.21 min ± 32.58 min vs 91.06 min ± 19.12 min, P < 0.05), and the length of incision and intraoperative blood loss for the study group were significantly lower than those for the control group (3.43 cm ± 0.86 cm vs 16.22 cm ± 2.17 cm, 15.76 mL ± 2.38 mL vs 95.23 mL ± 14.79 mL, P < 0.05). The visual analogue scale score and the times to recovery of gastrointestinal function and ambulation for the study group were significantly better than those for the control group (3.01 ± 1.06 vs 6.69 ± 1.21, 80.26 h ± 16.11 h vs 122.08 h ± 20.87 h, 1.92 d ± 0.68 d vs 3.39 d ± 1.07 d, P < 0.05). The rate of complications for the study group was significantly lower than that for the control group (4.44% vs 25.53%, P < 0.05). The duration of hospital stay for the study group was significantly lower than that for the control group (5.15 d ± 1.52 d vs 9.09 d ± 2.21 d, P < 0.05). The total treatment cost for the study group was significantly higher than that for the control group (23989.44 yuan ± 388.26 yuan vs 19151.06 yuan ± 226.75 yuan, P < 0.05). There was no significant difference in the rate of ulcer healing situation (37.78% vs 36.17%, 13.33% vs 10.64%, 31.11% vs 34.04%, 17.78% vs 19.15%, P > 0.05). CONCLUSION: Laparoscopic repair of gastroduodenal ulcer perforation is associated with minimal trauma, faster postoperative recovery, fewer complications, and shorter hospitalization time than open surgery. © 2015 Baishideng Publishing Group Inc. All rights reserved.


PubMed | Central Hospital of Nanyang
Type: Journal Article | Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine | Year: 2015

Sphingosine kinase 1 (SphK1) is an oncogenic enzyme promoting transformation, proliferation, and angiogenesis of a number of human tumors. However, its effect on hepatocellular carcinoma (HCC) behavior has not been fully clarified. The purpose of this study was to determine the correlation between HCC and SphK1, and to evaluate the effect of SphK1 inhibitor N,N-dimethylsphingosine (DMS) in HCC. The expression of SphK1 was measured in tissue samples from 76 HCC and paired adjacent noncancerous liver tissues (NT) by immunohistochemistry, quantitative real-time PCR, and Western blotting analysis. The effect of DMS was tested on HCC cells by evaluating cell viability in vitro. Transwell cell migration and invasion assay were carried out for functional analysis. Furthermore, Western blotting analysis was performed to examine the impact of DMS on the PI3K/Akt/NF-kB signaling. High expression of Sphk1 was observed in 84.21% (64/76) of the HCC versus 15.79% (12/76) of the adjacent non-tumorous liver tissues; the difference of Sphk1 expression between HCC and the adjacent non-tumorous liver tissues was statistically significant (P<0.001). The results were confirmed by Western blot analyses and quantitative real-time PCR. DMS inhibited the proliferation of SK-Hep1 and MHCCLM3 cells which have a relatively high level of SphK1 in a time- and concentration-dependent manner, and the invasion and migration of SK-Hep1 cells were distinctly suppressed after undergoing treatment with DMS. Furthermore, DMS markedly suppressed the expression of phosphorylations of Akt and NF-B in HCC cells. Our data suggest that the pathogenesis of human HCC maybe mediated by Sphk1, and the specific Sphk1 inhibitor DMS can play a therapeutic role in the treatment of HCC and thus, Sphk1 could represent selective targets for the molecularly targeted treatments of HCC.


Yang Y.,Central Hospital of Nanyang | Song Z.,Central Hospital of Nanyang | Wang G.,Central Hospital of Nanyang | Liu J.,Central Hospital of Nanyang
Life Science Journal | Year: 2013

Objective To investigate the tumor marker carbohydrate antigen CA19-9 in the diagnosis of early pancreatic cancer (PCA) and to find the value and significance of early diagnosis. Methods In our hospital from February 2010 to October 2012, 35 patients among treated with pancreatic cancer, it is set to the observation group, while 40 patients healthy subjects were set as the reference group. Chemiluminescence immunoassay method for the observation group and the reference group of healthy patients with pancreatic cancer by measuring tumor markers carbohydrate antigen CA19-9 levels, and clinical correlation. Results The group of 35 patients with serum CA19-9 levels were significantly higher than the reference group of healthy subjects, the positive rate of 86.9% of the observation group, the positive rate of 7.3% in the reference group, two groups, the difference was statistically significant sex significance (P <0.05). Conclusion Early diagnosis of pancreatic cancer, on the determination of CA19-9 is very important in the clinical value, is deemed reliable indicators can improve the early diagnosis of pancreatic cancer.


Yang Y.,Central Hospital of Nanyang | Song Z.,Central Hospital of Nanyang | Wang G.,Central Hospital of Nanyang | Liu J.,Central Hospital of Nanyang
Life Science Journal | Year: 2013

Objective: To investigate the clinical efficacy of laparoscopic treatment of acute abdomen. Methods: In our hospital, from January 2009 to January 2012 general surgery patients using laparoscopic treatment of acute abdomen clinical data of 260 patients were analyzed retrospectively. Results: The patient operative time 25 ~ 210min, bleeding 5 ~ 350ml, hospital days 4 to 20 days, with an average hospital stay of approximately (7.17 ± 2.35) days, bowel function returned to normal average of 2.5 days. Postoperative pain, were cured, Conclusion: Laparoscopic General Surgery abdomen with less trauma, less pain, faster recovery, no scar, small chance of complications and other advantages, it is widely in clinical practice.

Loading Central Hospital of Nanyang collaborators
Loading Central Hospital of Nanyang collaborators